RX DM is a specialist medical practice in Dilbeek. Private Limited, started on 15 March 2019, 1 establishment.

What is the address of RX DM?

The registered office of RX DM is located at Kerselaarstraat 8, 1700 Dilbeek.

Is RX DM still active?

Yes. According to the CBE (29 September 2026) RX DM is active, legal situation “Normale toestand”, started on 15 March 2019.

Is RX DM registered on Peppol?

Yes, RX DM is registered on the Peppol network with ID 0208:0722787085.

What is the enterprise number of RX DM?

The enterprise number of RX DM is BE0722787085.

When was RX DM founded?

RX DM was founded on 15 March 2019.

Who are the directors of RX DM?

According to the 2025 annual accounts, the directors of RX DM are: Floris De Munck.

Is RX DM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 March 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did RX DM make in 2025?

RX DM posted a profit after taxes of € 64,528 in financial year 2025.

What is the revenue of RX DM?

As a small company, RX DM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 127,963.

RX DM (Private Limited) - Dilbeek - BE0722787085

Dossier RX DM, printed on 29 September 2026 from databakkes.be/en/0722787085/rx-dm. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

RX DM from Dilbeek, company number BE0722787085, closed financial year 2025 with a result of € 64,528 after tax. For that financial year RX DM recorded a gross margin of € 127,963 and equity of € 130,256. Compared with financial year 2024, the result moved from € 50,788 to € 64,528. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 130,256

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 64,528

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,374

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,000 paid out

85 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,571

▲ 72% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,310

▼ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 752

▲ € 718 vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 53,418 Gross margin 2022: € 53,418 First fiscal year in the series	€ 110,219 Gross margin 2023: € 110,219 ▲ 106% vs 2022 (€ 53,418) Favourable step	€ 111,090 Gross margin 2024: € 111,090 ▲ 1% vs 2023 (€ 110,219) Favourable step	€ 127,963 Gross margin 2025: € 127,963 ▲ 15% vs 2024 (€ 111,090) Favourable step	▲ 15%
Profit after taxes	€ 1,222 Profit after taxes 2022: € 1,222 First fiscal year in the series	€ 48,761 Profit after taxes 2023: € 48,761 ▲ € 47,539 vs 2022 (€ 1,222) Favourable step	€ 50,788 Profit after taxes 2024: € 50,788 ▲ 4% vs 2023 (€ 48,761) Favourable step	€ 64,528 Profit after taxes 2025: € 64,528 ▲ 27% vs 2024 (€ 50,788) Favourable step	▲ 27%
Equity	€ 120,728 Equity 2022: € 120,728 First fiscal year in the series	€ 120,728 Equity 2023: € 120,728 Unchanged (€ 120,728) Unchanged	€ 120,728 Equity 2024: € 120,728 Unchanged (€ 120,728) Unchanged	€ 130,256 Equity 2025: € 130,256 ▲ 8% vs 2024 (€ 120,728) Favourable step	▲ 8%
Total debts	€ 75,560 Total debts 2022: € 75,560 First fiscal year in the series	€ 36,800 Total debts 2023: € 36,800 ▼ 51% vs 2022 (€ 75,560) Favourable step	€ 56,474 Total debts 2024: € 56,474 ▲ 53% vs 2023 (€ 36,800) Unfavourable step	€ 59,490 Total debts 2025: € 59,490 ▲ 5% vs 2024 (€ 56,474) Unfavourable step	▲ 5%
Cash	€ 8,834 Cash 2022: € 8,834 First fiscal year in the series	€ 3,895 Cash 2023: € 3,895 ▼ 56% vs 2022 (€ 8,834) Unfavourable step	€ 90,102 Cash 2024: € 90,102 ▲ € 86,206 vs 2023 (€ 3,895) Favourable step	€ 58,374 Cash 2025: € 58,374 ▼ 35% vs 2024 (€ 90,102) Unfavourable step	▼ 35%
Retained profit	€ 102,128 Retained profit 2022: € 102,128 First fiscal year in the series	€ 102,128 Retained profit 2023: € 102,128 Unchanged (€ 102,128) Unchanged	€ 102,128 Retained profit 2024: € 102,128 Unchanged (€ 102,128) Unchanged	€ 111,656 Retained profit 2025: € 111,656 ▲ 9% vs 2024 (€ 102,128) Favourable step	▲ 9%
Dividend	€ 29,983 Dividend 2022: € 29,983 First fiscal year in the series	€ 48,761 Dividend 2023: € 48,761 ▲ 63% vs 2022 (€ 29,983) Unchanged	€ 50,788 Dividend 2024: € 50,788 ▲ 4% vs 2023 (€ 48,761) Unchanged	€ 55,000 Dividend 2025: € 55,000 ▲ 8% vs 2024 (€ 50,788) Unchanged	▲ 8%
Balance sheet total	€ 196,288 Balance sheet total 2022: € 196,288 First fiscal year in the series	€ 157,528 Balance sheet total 2023: € 157,528 ▼ 20% vs 2022 (€ 196,288) Unchanged	€ 177,201 Balance sheet total 2024: € 177,201 ▲ 12% vs 2023 (€ 157,528) Unchanged	€ 189,746 Balance sheet total 2025: € 189,746 ▲ 7% vs 2024 (€ 177,201) Unchanged	▲ 7%

Key figures of RX DM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to RX DM?

What happened at RX DM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 64,528 (▲ 27% vs 2024). Source: NBB ↗
Mar 15, 2019 New establishment in Dilbeek. KBO
Mar 15, 2019 Start of the company according to the CBE. KBO

In short

From € 1,222 profit in 2022 to € 64,528 profit in 2025.

Paid € 49,616 in corporate taxes since 2022.

Best year ever: 2025, with € 64,528 profit.

Paid out € 184,531 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at RX DM? We notify you, reason included.

Follow RX DM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Floris De Munck

RX DM

Behind RX DM is Floris De Munck.

See the full network in the app

Directors

According to the 2025 annual accounts

Floris De Munck

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kerselaarstraat 8

1700 Dilbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0722.787.085

VAT number

BE 0722.787.085

Registered office

Kerselaarstraat 8, 1700 Dilbeek

Names & denominations

RX DM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 March 2019

Peppol

Active · Active since 27 Nov 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

RX DM

Financials

What happened to RX DM?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions